LINKINGUP Scandi Standard acquires Bosarpskyckling AB
S
candi Standard, through its subsidiary Kronfågel AB, is acquiring the Swedish organic and KRAV-approved chicken producer Bosarpskyckling AB. The acquisition will give Kronfågel AB an expanded customer offering, helping to meet the ever-stronger demand for organic food. Bosarpskyckling AB is Sweden’s leading producer of organic broiler chickens under the Bosarp brand. “This acquisition is in line with our long-term strategy of offering consumers healthy and climatesmart chicken products,” says Leif Bergvall Hansen, CEO of Scandi Standard.
“Demand for white meat is growing, and the acquisition will enable Kronfågel AB to further develop and strengthen its customer offering with KRAV-approved, organic premium chicken,” says Magnus Lagergren, CEO of Kronfågel AB. “We are delighted that Kronfågel AB will be our new owner,” says the Alwén family via Birgitta Alwén. “Together, Bosarp and Kronfågel will develop our business to meet the growing demand for Bosarp’s organic chicken.” The acquisition is expected to be completed during the third quarter of 2014. Visit: www.scandistandard.com
Trelleborg divests rubber boot facility T DPx Holdings to acquire Gallus BioPharmaceuticals
D
Px Holdings BV, privately owned by JLL Partners and Royal DSM, has reached a definitive agreement to acquire all shares of Gallus BioPharmaceuticals, LLC, a leading contract manufacturing company specialising in biologics and current portfolio company of Ridgemont Equity Partners. Following the transaction, Patheon’s biologic drug substance business, a unit of DPx Holdings, will span four facilities in Europe, Australia and North America and include 550 employees globally. DPx Holdings is the parent company of Patheon, DSM Fine Chemicals and Banner Life Sciences. The Patheon pharma services business provides commercial manufacturing, pharmaceutical product development services for a full array of solid and sterile dosage forms, and biologic and chemical drug substance development and manufacturing. The addition of Gallus BioPharmaceuticals makes Patheon a leading provider of process development as well as clinical and commercial scale manufacturing of mammalian cell culture derived products. Patheon can offer its customers a broad array of disposable manufacturing technology, as well as commercial scale production, throughout its global network. Visit: www.patheon.com
Merger in CO2 and dry ice sector
T
he German firm BUSE Gastek GmbH, headquartered in Bad Hönningen, is merging its business divisions for CO2 production and recovery plant construction and dry ice technology with the Swiss company ASCO CARBON DIOXIDE LTD, headquartered in Romanshorn. Employees of BUSE Gastek working in these divisions will be transferred
to ASCO, a subsidiary of the German specialist in industrial gases Messer Group. Based on sales figures for 2013, the merger will result in a competitive company with an estimated annual turnover of €32 million. The joint venture will operate under the name ASCO CARBON DIOXIDE LTD. The joint venture offers solutions for a wide range of CO2 sources, whether natural
relleborg has signed an agreement to divest a facility that manufactures rubber boots for light vehicles. The business operation is based in Spain and is part of the Trelleborg Industrial Solutions business area. The buyer is the French Group Delmon Industrie SA. Trelleborg is active in the production of polymer boots for drive shaft (constant velocity joints) and steering systems (rack and pinion) for light vehicles. Generally, two materials are used for boots in these applications, either rubber or thermoplastic elastomer (TPE). Trelleborg supplies boots in both materials. The market demand for TPE boots for constant velocity joints and rack and pinion is steadily increasing, while demand for rubber boots is shrinking. Trelleborg is therefore divesting its Spanish business operation that solely manufactures rubber boots for constant velocity joints. Visit: www.trelleborg.com
sources, stack gas, brewing and other fermentation processes, ammonia, hydrogen or ethylene oxide production, or a host of other industrial sources. “The merger will allow us to combine and expand our core competencies and pool our strengths,” enthuses ASCO managing director, Marco Pellegrino. Visit: www.buse-gastek.com Industry Europe 19
